Anti-annexin V does not belong to the aPL criteria in APS according to Sydney recommendations [8], and therefore, even if patients meet the clinical manifestations of APS, they do not meet the laboratory criteria and are considered SN-APS. This evidence concerns the gene ANXA5 and autoimmune polyendocrinopathy.